(Q34626253)

English

Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS clinical trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

paroxysmal nocturnal hemoglobinuria

1 reference

based on heuristic

inferred from title

Kazuma Ohyashiki

2

object named as

Kazuma Ohyashiki

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Yuzuru Kanakura

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Tsutomu Shichishima

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Shinichiro Okamoto

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Kiyoshi Ando

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Haruhiko Ninomiya

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Tatsuya Kawaguchi

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Shinji Nakao

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Hideki Nakakuma

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jun-ichi Nishimura

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Taroh Kinoshita

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Camille L Bedrosian

12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Marye Ellen Valentine

13

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Gus Khursigara

14

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Keiya Ozawa

15

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Mitsuhiro Omine

16

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

12 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

93

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

36-46

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

https://scigraph.springernature.com/pub.10.1007/s12185-010-0748-9

0 references

Cerebral ischemic infarction in paroxysmal nocturnal hemoglobinuria report of 2 cases and updated review of 7 previously published patients

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

Fatigue in cancer patients compared with fatigue in the general United States population.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

Headache characteristics during the development of tolerance to nitrates: pathophysiological implications

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

The role of nitric oxide in the regulation of glomerular haemodynamics in humans

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

Effects of nitric oxide synthase blockers on renal function

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

Natural history of paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

Diagnosis and management of paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

The pathophysiology of paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0748-9

21 January 2018

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

1 reference

https://pubmed.ncbi.nlm.nih.gov/21222185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The kidneys in paroxysmal nocturnal hemoglobinuria

1 reference

https://pubmed.ncbi.nlm.nih.gov/21222185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories

1 reference

https://pubmed.ncbi.nlm.nih.gov/21222185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatic mutations of the PIG-A gene found in Japanese patients with paroxysmal nocturnal hemoglobinuria

1 reference

https://pubmed.ncbi.nlm.nih.gov/21222185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/21222185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/21222185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21222185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21222185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/21222185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Basal nitric oxide synthase activity is a major determinant of glomerular haemodynamics in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/21222185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-010-0748-9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34626253&oldid=1557415760"